Saifuyuzu

4892.TPharmaceutical
Filed as Cyfuse Biomedical K.K. (2023-03–2026-08)
Major holders (5%+) · 2
HolderStakeChangeFiled
Shizuka Akieda7.31%-1.02pp2026-04-28
Masahiro Sanjo6.74%+1.26pp2025-05-07

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 3
SBI Ventures Two Co., Ltd.4.64%2026-05-12
SBI Shinsei Bank, Limited2.24%2026-05-12
SBI SECURITIES Co., Ltd.0.83%2026-05-12
Ownership history · 74
FiledHolderRatioChangePurpose
2024-07-02AmendedSBI Shinsei Bank, Limited2024-07-02 · amended2.74%no changePure investment
2024-07-02AmendedSBI SECURITIES Co., Ltd.2024-07-02 · amended3.22%-0.16ppSecurities trading business
2024-07-02AmendedSBI Ventures Two Co., Ltd2024-07-02 · amended6.03%no changePure investment
2024-06-05AmendedSBI Shinsei Bank, Limited2024-06-05 · amended2.74%-0.08ppPure investment
2024-06-05AmendedSBI SECURITIES Co., Ltd.2024-06-05 · amended3.38%+0.72ppSecurities trading business
2024-06-05AmendedSBI Ventures Two Co., Ltd.2024-06-05 · amended6.03%-0.18ppPure investment
2024-03-18AmendedSBI SECURITIES Co., Ltd.2024-03-18 · amended2.66%+0.23ppSecurities trading business
2024-03-18AmendedSBI Shinsei Bank, Limited2024-03-18 · amended2.82%no changePure investment
2024-03-18AmendedSBI Ventures Two Co., Ltd.2024-03-18 · amended6.21%no changePure investment
2024-02-15AmendedSBI SECURITIES Co., Ltd.2024-02-15 · amended2.43%newSecurities trading business
2024-02-15AmendedSBI Shinsei Bank, Limited2024-02-15 · amended2.82%newPure investment
2024-02-15AmendedSBI Ventures Two Co., Ltd.2024-02-15 · amended6.21%newPure investment
2024-01-23Shizuka Akieda2024-01-236.88%newStable shareholder; Long-term holding
2024-01-23Masahiro Sanjo2024-01-235.48%newStable shareholder; Long-term holding

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.